The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 14, 2022
Filed:
Apr. 10, 2019
Applicant:
Shenzhen Targetrx, Inc., Guangdong, CN;
Inventors:
Assignee:
Shenzhen TargetRx, Inc., Guangdong, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/22 (2006.01); C07D 487/04 (2006.01); C07D 487/22 (2006.01); C07D 498/22 (2006.01); A61K 31/04 (2006.01); A61K 31/519 (2006.01); A61P 29/00 (2006.01); A61P 25/04 (2006.01); A61P 25/28 (2006.01); A61P 35/00 (2006.01); C07D 487/18 (2006.01); C07D 498/18 (2006.01);
U.S. Cl.
CPC ...
C07D 498/22 (2013.01); A61P 35/00 (2018.01); C07D 471/22 (2013.01); C07D 487/18 (2013.01); C07D 487/22 (2013.01); C07D 498/18 (2013.01);
Abstract
A di(hetero)aryl macrocyclic compound having an inhibitory effect on protein kinase activity, preparation and the use thereof. Specifically, disclosed are a di(hetero)aryl macrocyclic compound represented by formula (I), or a pharmaceutically acceptable salt, an enantiomer, a diastereomer, a racemate, a solvate, a hydrate, a polymorph, a prodrug or an active metabolite thereof, a pharmaceutical composition comprising said compound and the derivative thereof, and methods of using the same, including methods of treating cancers, pain, neurological diseases, autoimmune diseases and inflammation.